Insmed Inc (NAS:INSM)
$ 69.61 -1.06 (-1.5%) Market Cap: 12.45 Bil Enterprise Value: 12.18 Bil PE Ratio: 0 PB Ratio: 25.75 GF Score: 67/100

Insmed Inc at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 12, 2021 / 12:30PM GMT
Release Date Price: $36.51 (+9.97%)
Felipe Velasquez
JP Morgan Chase & Co. - VP of Healthcare Investment Banking

Welcome, everyone, to the 39th Annual JPMorgan Healthcare Conference. My name is Felipe Velasquez, the Vice President on our Health Care Investment Banking team. I'm here with our next presenting company's Chairman and CEO, Will Lewis of Insmed. (Operator Instructions)

I'll now turn it over to Will.

William H. Lewis
Insmed Incorporated - President, CEO & Chairman

Thank you. Referring to the forward-looking statement slide, I'd like to ask you to review our filings with the SEC for important disclosures.

Please turn to Slide 3. More than any other year in our company's history, 2020 was the year of our greatest transformation. The last year has seen the evolution of Insmed from 1- into a 3-program story. Critically, each of these programs or pillars, as we like to think of them, could potentially become the cornerstone of treatment in each of their diseases. I cannot overstate the degree of positive change in terms of patient impact, business

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot